AstraZeneca Pharma P/E Ratio

Current P/E Ratio
86.7
High Valuation
Very High - High growth expectations or significantly overvalued

AstraZeneca Pharma P/E ratio. AstraZeneca Pharma (ASTRAZEN) P/E ratio is 86.7 (High), EPS (TTM) ₹75.01, current price ₹6113.00 on NSE — Very High - High growth expectations or significantly overvalued. Also explore AstraZeneca Pharma stock price data download to track price trends across different timeframes.

Current Valuation Metrics

P/E Ratio 86.7
Current Price ₹6113.00
EPS (TTM) ₹75.01
Exchange NSE

Valuation Signal

Signal Overvalued

Sector Context

Sector Average 52.06
Sector Median 29.4
Sector Rank #11 of 255
Sector Percentile 4.3%

ASTRAZEN P/E Ratio — Valuation Signal & Historical Context

AstraZeneca Pharma P/E 86.7 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see AstraZeneca Pharma share price chart.

  • Stock appears overvalued with PE of 86.7, suggesting caution for new investments
  • Trading at premium to sector average PE of 52.06

ASTRAZEN vs Healthcare Peers — P/E Ratio Comparison

AstraZeneca Pharma P/E 86.7 vs Healthcare average 52.06, median 29.4 — range 2.0–733.0.

Sector Average
52.06
Sector Median
29.4
Lowest P/E
2.0
Highest P/E
733.0
Companies
255
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.0 ₹72 Low
Brooks Laboratories BROOKS 2.6 ₹206 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.3 ₹54 Low
Sun Pharma Advanced Rese… SPARC 4.1 ₹6,355 Low
Dipna Pharmachem DPL 4.5 ₹11 Low
JFL Life Sciences JFLLIFE 4.7 ₹82 Low
Royal Sense ROYAL 4.8 ₹34 Low
Star Imaging And Path Lab STARIMAGIN 5.3 ₹110 Low
Kabra Drugs KABRADG 6.3 ₹49 Low